Pharma supply chains suffer on regulations

Regulatory pressures are at the top of the list of supply chain concerns voiced by pharmaceutical manufacturers in an annual UPS poll. Among respondents with more than $1 billion in sales, an increased regulatory burden was the top concern of 56 percent, while this factor topped the list for a third of smaller drugmakers. Report

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.